Novo Nordisk CEO on earnings: Very bullish on 2025 despite demand concerns

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

Related Posts

American Airlines CEO Robert Isom on Q3 results: Our te...

admin Oct 25, 2024  0  4

AI enhances conversational language learning, says Duol...

admin May 17, 2024  0  4

Moderna CEO Stephane Bancel on Q2 results, slashing its...

admin Aug 2, 2024  0  14

Comments

Name

Email

Comment

Post Comment